Diabetes Care in The Netherlands: - Novo Nordisk

More documents

Recommendations

Info

DiabetesDiabeteshashasa highhighpreventionpreventionpotentialpotentialforforlostlostproductivityproductivityDiabetes is a common condition in workforce15 – 65 years of age, 2009, ‘000, %Good treatment increases participation substantially26112.7%• Quality of primary care is really good. The vastmajority of patients have excellent values and canlive active lives’Prof. dr. Guy Rutten; Julius Center923.3%• The life expectancy in our treatment program ofType 2 patients is the same as the generalpopulation due to earlier diagnostics and highquality care’Prof. dr. Henk Bilo; VUMCWorkgroupagediabeticsDisabledwith diabetics% diabetics % diabeticsof workforce ofdisabled• ‘Type 1 patients, when adhering to the medication,are able to have a relative normal life and performwell in most types of jobs’Prof. dr. Cees Tack, UMC St RadboudLimited insight in the reasons why diabetes patients obtainworking disabilitiesSource: CBS CBS Statline, UWV, Booz Booz & & Company AnalysisBooz & Company 14 November 201146Prepared for Novo Nordisk39
However, curative and participative care are still two differentworldsCurative CareParticipative CareCompanyGPDiabetic nursePatientSpecialistDieticianArbo-medicCompanymedicEmbedded in private lifeRole• How to prevent complications• No advice on participationInsurancemedicEmbedded in professional lifeRole• How to improve participation in society• How to change working environment• No advice on treatmentSource: Booz & Company AnalysisSource: Booz & Company AnalysisBooz & Company 14 November 2011Prepared for Novo Nordisk4047
Page 6 and 7: SummaryDiabetes is a serious and de
Page 8: diabetes care. Extra compensation w
Page 11 and 12: ContentsSummarized findings and rec
Page 13 and 14: 11Diabetes is a major and underesti
Page 15 and 16: 33Further improving health of of di
Page 17 and 18: 22Recommendation 2: Engage employer
Page 19 and 20: 44Recommendation 4: Introduce condi
Page 21 and 22: Already more than 1M diabetes patie
Page 23 and 24: Costs of of complications and treat
Page 25 and 26: Number of patients reaches ~1.4M in
Page 27 and 28: Increase in lost productivity is dr
Page 29 and 30: Diabetes care clearly improved in t
Page 31 and 32: Better compliance can be stimulated
Page 37 and 38: Delaying complications saves medica
Page 39 and 40: LimitedLimitedcollaborationcollabor
Page 41 and 42: Individual quality incentives are l
Page 43 and 44: Recommendation 1: Insurer should in
Page 47: Labour shortage from late nineties
Page 53 and 54: Non-compliance leads to severe comp
Page 55: Facilitated patient networks are su
Page 58 and 59: Recommendation 3:Facilitate network
Page 62 and 63: But new medication could add a lot
Page 66: Booz & Company is a global manageme

Diabetes Care in The Netherlands: - Novo Nordisk

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?